Outgrace, home

What public data can and cannot tell you about health care capital

No public source in our set measures asset needs for clinics, diagnostics or care services. Here is what the data does support, and how to set a funding mix without it.

Self care, self, care, self-reliance, health, mental health

About 2 billion people face severe financial hardship from health costs, according to the World Bank. Yet none of the five public sources we reviewed gives a single asset, capital expenditure or funding-mix figure for a clinic, a diagnostic service or a care-services business. That gap matters to any leader trying to choose how a health business should be financed, because public evidence cannot settle the question on its own.

This piece is written for chief executives, finance directors and board members deciding between equity, debt, leases and grants. The question is sound, and the answer from public data is partial. What follows sets out what the sources do support, where the evidence stops, and the tests we would apply in its place. Where a point is our judgement rather than a sourced fact, we say so.

People facing severe financial hardship from health costs, per the World Bank
2 billion
People the World Bank's Health Works initiative aims to serve with quality care by 2030
1.5 billion
Programme giving vulnerable patients GP support this winter, UK Department of Health and S
£40 million

What the data shows

The most detailed public statistics in this set come from CMS, the US agency that publishes the National Health Expenditure Accounts. Those accounts track spending by type of service, including hospital care, physician and clinical services, and retail prescription drugs. They also split spending by source of funding, such as private insurance, Medicare, Medicaid and out-of-pocket payments, and by sponsor, meaning businesses, households and governments. Ten-year projections sit alongside the historical series, using the same breakdowns.

What those accounts leave out matters more for this question. CMS's own description is of spending by type of good or service delivered, and our reading of the listed categories is that the data gives no capital or asset split for providers. It records money flowing through the system, not the buildings, scanners and fit-outs that a provider owns or rents. A consultation fee and a scan may sit in neighbouring categories whether the provider owns its equipment or pays someone else to supply it, so the accounts cannot tell a capital-heavy service from a light one.

CMS also publishes personal health care spending by State of Provider, covering all 50 States and DC. In that cut, however, only Medicare and Medicaid funding appears. A reader looking for a state-level picture of how private funding and capital interact will not find it there. The cut is useful for tracking public payer flows by geography, and it should not be read as a guide to provider investment.

The World Health Organization places financing among the basic jobs of a health system: raising money, pooling it and using it for services, with universal health coverage as the aim. Its guidance on use stresses that timely disbursement to providers supports adequate staffing and medicines. It also points to contracting and payment arrangements as a way to encourage care coordination and quality. For a provider, that means the payment mechanism is part of the business model, and it shapes the revenue that any capital must be repaid from.

WHO also warns against judging a system by its label. Terms such as social health insurance or tax-funded say little on their own. The organisation says reforms cannot simply be copied from one country to another, because context and starting point differ. It notes that patients often pay out of pocket, through co-payments, for services that are not covered. For a leader, the practical reading is that a payer label tells you little about how a provider will be paid. The contract, the coverage rules and the co-payment level tell you much more.

The World Bank's Health Works initiative sets a target of 1.5 billion people served with decent-quality care by 2030, and it says outright that it wants private firms involved. The bank states that private companies, public institutions and governments are all needed for infrastructure and technology to scale primary health services. It describes investment in infrastructure and technology as central to growth and job creation. It also cites shrinking fiscal space as a constraint on affordable access. The bank gives no capital figures to support those claims, so the invitation to invest is clear while its size is not.

The UK Department of Health and Social Care is a ministerial department supported by 23 agencies and public bodies. Its pages describe a £40 million programme to give hundreds of thousands of vulnerable patients GP support this winter, a neighbourhood approach to commissioning social care, and a blood-test trial for cancer detection involving tens of thousands of patients. None of those announcements gives a cost or capital figure for the providers who would deliver them. A public buyer can still shape demand for a service, but the sources do not show what it takes to supply that service.

Figures in the public sources

Each figure is as its publisher states it. None measures the asset base, capital spending or funding mix of a clinic, diagnostic or care-services provider.

People facing severe financial hardship from health costs (World Bank)
2 billion
Share of the global population lacking essential health services (World Bank)
Half
People the Health Works initiative aims to serve by 2030 (World Bank)
1.5 billion
GP support programme for vulnerable patients this winter (UK DHSC)
£40 million

Source: World Bank; gov.uk

What it means for a leader

The one hard rule in this set that bears directly on capital is an accounting rule. According to the IFRS Foundation, IFRS 16 took effect for annual periods beginning on or after 1 January 2019, with early application allowed if IFRS 15 was also applied. It requires lessees to book a right-of-use asset and a matching lease liability for leases running beyond twelve months, with an exemption for low-value underlying assets. It replaced IAS 17, IFRIC 4, SIC-15 and SIC-27 and introduced a single model for lessees.

The practical effect for health providers follows from that rule. The IFRS Foundation's terms place leased clinic sites, diagnostic equipment and care premises on the balance sheet as lease liabilities. A lease-heavy operator can therefore show more debt-like obligations than a peer that owns similar assets outright, even when its cash operations look much the same. Any comparison of leverage between two providers has to start by asking how each has treated its leases.

In our judgement, capital intensity has to be answered line by line before a funding mix is chosen. Clinics, diagnostic services and care services differ in how much equipment must be bought or replaced, how quickly that equipment ages, how many premises must be secured, and how far revenue depends on a single payer's decision. The public sources cannot give those values for any sector. Treat any benchmark that claims to come from them with suspicion until its own source is produced.

The main routes to money each carry a different claim. Equity gives an investor a share of the outcome and usually a voice in decisions. Debt brings scheduled repayments and covenants that the lender can enforce. Leases spread the cost of premises or machines over time, and under IFRS 16 they now appear as liabilities. Grants and public funding come with conditions set by the funder. Which mix suits a given site depends on how long its assets last and how much of its income is contracted in advance.

The sources identify three groups who should care about this. Public payers and national health systems are the first, because their payment rules shape the revenue that providers can borrow against. Providers that lease premises or equipment are the second, because the accounting rule moves those commitments onto their balance sheets. Private-sector health investors are the third, since the World Bank's Health Works initiative explicitly seeks their involvement. No clinic, diagnostic or care-services company is named in the sources, so none of these groups can be matched to a specific business from this set.

A simple test helps before any approach to a lender or investor. List every site and item of equipment the business uses, and mark which of them are leased on terms longer than twelve months. Estimate how those leases would appear as liabilities and how they would change the leverage figure your lenders watch. Then read the definitions page of each facility agreement to see which debt and earnings measures actually apply. Finally, ask which payer contracts will repay any new borrowing, and how predictable that stream is.

Whether a particular lease, loan or grant suits a particular site is a question for an accountant and a lawyer, who will read the lease, the facility agreement and any funding conditions in full. The questions to put to them are specific. Which leases count as liabilities under the applicable accounting rules? Which covenant definitions would a bad quarter test? Which conditions attach to public money, and what happens if they are breached?

Limits of the data

The limits are substantial. First, no source in this set reports asset bases, capital spending or debt shares for clinics, diagnostic services or care services, so no ranking of capital intensity can be drawn from it. Second, the CMS series measures spending flows, not balance sheets, while the WHO and World Bank material concerns national policy and system design. Third, the World Bank's call for private investment is a statement of intent, not evidence of what investment earns. Fourth, no clinic, diagnostic or care-services company is named in the sources, and none of the five is a company filing. The comparison this piece set out to make therefore needs company annual reports of listed providers, which have not been checked here.

Until that work is done, the honest position is narrow. The public data explains how money flows through health systems and how a lease will be recorded. It does not say how much capital a clinic, a diagnostic laboratory or a care business needs, or how those businesses are typically financed. A leader who needs that answer should ask the provider's own filings and advisers for it, and should distrust any figure presented without a named source.

Newsletter

The Briefing

One email a week: the leaders we profiled, the ideas worth stealing, and nothing else.

Weekly, free, one click to leave. Read our privacy policy.